Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2).

Saved in:
Bibliographic Details
Title: Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2).
Authors: Riselli AM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Yee SW; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Yang J; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Brett CM; Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California, USA., Trumbach K; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Zhou X; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Liu R; Drug Metabolism, Gilead Sciences Inc., Foster City, California, USA., Liang X; Drug Metabolism, Gilead Sciences Inc., Foster City, California, USA., Lai Y; Drug Metabolism, Gilead Sciences Inc., Foster City, California, USA., Huo R; Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, Princeton, New Jersey, USA., Xue Y; Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, Princeton, New Jersey, USA., Shen H; Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, Princeton, New Jersey, USA., Zhang L; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Yang X; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Liu Q; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Huang SM; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Giacomini KM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2025 Jul; Vol. 118 (1), pp. 177-189. Date of Electronic Publication: 2025 Apr 01.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40170495
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Riselli+AM%22">Riselli AM</searchLink>; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Yee+SW%22">Yee SW</searchLink>; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Yang+J%22">Yang J</searchLink>; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Brett+CM%22">Brett CM</searchLink>; Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Trumbach+K%22">Trumbach K</searchLink>; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+X%22">Zhou X</searchLink>; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Liu+R%22">Liu R</searchLink>; Drug Metabolism, Gilead Sciences Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Liang+X%22">Liang X</searchLink>; Drug Metabolism, Gilead Sciences Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Lai+Y%22">Lai Y</searchLink>; Drug Metabolism, Gilead Sciences Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Huo+R%22">Huo R</searchLink>; Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Xue+Y%22">Xue Y</searchLink>; Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Shen+H%22">Shen H</searchLink>; Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, Princeton, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Yang+X%22">Yang X</searchLink>; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Liu+Q%22">Liu Q</searchLink>; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Huang+SM%22">Huang SM</searchLink>; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Giacomini+KM%22">Giacomini KM</searchLink>; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2025 Jul; Vol. 118 (1), pp. 177-189. <i>Date of Electronic Publication: </i>2025 Apr 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40170495
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cpt.3657
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 177
    Titles:
      – TitleFull: Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Riselli AM
      – PersonEntity:
          Name:
            NameFull: Yee SW
      – PersonEntity:
          Name:
            NameFull: Yang J
      – PersonEntity:
          Name:
            NameFull: Brett CM
      – PersonEntity:
          Name:
            NameFull: Trumbach K
      – PersonEntity:
          Name:
            NameFull: Zhou X
      – PersonEntity:
          Name:
            NameFull: Liu R
      – PersonEntity:
          Name:
            NameFull: Liang X
      – PersonEntity:
          Name:
            NameFull: Lai Y
      – PersonEntity:
          Name:
            NameFull: Huo R
      – PersonEntity:
          Name:
            NameFull: Xue Y
      – PersonEntity:
          Name:
            NameFull: Shen H
      – PersonEntity:
          Name:
            NameFull: Zhang L
      – PersonEntity:
          Name:
            NameFull: Yang X
      – PersonEntity:
          Name:
            NameFull: Liu Q
      – PersonEntity:
          Name:
            NameFull: Huang SM
      – PersonEntity:
          Name:
            NameFull: Giacomini KM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1532-6535
          Numbering:
            – Type: volume
              Value: 118
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical pharmacology and therapeutics
              Type: main
ResultId 1